Financial Toxicity Among Patients With Traumatic Finger Amputation: A Retrospective Study
- PMID: 39548876
- PMCID: PMC11571134
- DOI: 10.1177/15589447241295288
Financial Toxicity Among Patients With Traumatic Finger Amputation: A Retrospective Study
Abstract
Background: Patients face increasing financial toxicity (FT), defined as emotional distress due to the cost of medical treatment. However, little is known regarding FT in the context of upper extremity trauma.
Methods: We surveyed patients who sustained traumatic finger amputation (October 21, 2011-January 1, 2021). We collected patient-reported financial distress using the Comprehensive Score for Financial Toxicity (COST-11), where a lower score indicates worse FT. We also collected data of patients' perceptions regarding the costs of their treatment. We used linear regression to assess patient-level characteristics associated with FT as measured by the COST-11 score.
Results: Of the 191 eligible patients, 46 patients completed the survey (response rate of 24%). A total of 41 respondents (89%) received an initial treatment of revision amputation, with the remaining patients receiving a semi-occlusive dressing. Patients with commercial insurance had significantly lower COST-11 scores (ie, worse FT) than patients with Medicare (β = 7.5, 95% CI: 0.5 to 14.5) and Worker's Compensation (β = 8.7, 95% CI: 1.8 to 15.6). Patients who were single/never married had significantly worse FT (β = -11.3, 95% CI: -18.7 to -3.9). Approximately 35% (n = 16) reported that the costs were higher than expected. More than a third of patients (39%) reported decreasing spending on basic items, such as food, at least once since surgery.
Conclusion: Patients face FT when obtaining surgery following traumatic finger amputation. Variation in the FT is associated with type of insurance and marriage status, highlighting how underinsurance and social support likely affect the overall economic well-being of patients.
Keywords: cost; financial toxicity; finger amputation.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: VA has received consulting fees from Third Culture Capital. EDS was supported by a Career Development Award Number IK2 HX002592 from the US Department of Veterans Affairs Health Services R&D (HSRD) Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the US government or Veterans Administration. This study was supported by a grant from the American Foundation for Surgery of the Hand. The other authors have no other conflicts of interest. Please see COI form and manuscript. There are two grants and then one author has consulting fees from third part capital.
Figures



Similar articles
-
A national cross-sectional survey of financial toxicity among bladder cancer patients.Urol Oncol. 2021 Jan;39(1):76.e1-76.e7. doi: 10.1016/j.urolonc.2020.09.030. Epub 2020 Oct 23. Urol Oncol. 2021. PMID: 33268274
-
Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer.Support Care Cancer. 2023 Jun 10;31(7):388. doi: 10.1007/s00520-023-07849-6. Support Care Cancer. 2023. PMID: 37300721 Free PMC article.
-
Financial Toxicity in Women With Breast Cancer Receiving Radiation Therapy: Final Results of a Prospective Observational Study.Pract Radiat Oncol. 2022 Mar-Apr;12(2):e79-e89. doi: 10.1016/j.prro.2021.11.003. Epub 2021 Dec 9. Pract Radiat Oncol. 2022. PMID: 34896597
-
Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.CA Cancer J Clin. 2022 Sep;72(5):437-453. doi: 10.3322/caac.21730. Epub 2022 May 18. CA Cancer J Clin. 2022. PMID: 35584404 Review.
-
Prevalence and risk factors of self-reported financial toxicity in cancer survivors: A systematic review and meta-analyses.J Psychosoc Oncol. 2023;41(4):457-474. doi: 10.1080/07347332.2022.2142877. Epub 2022 Nov 12. J Psychosoc Oncol. 2023. PMID: 36370039
References
-
- Adrion ER, Ryan AM, Seltzer AC, et al. Out-of-pocket spending for hospitalizations among nonelderly adults. JAMA Intern Med. 2016;176(9):1325-1332. - PubMed
-
- Johansen ME, Yun JD. Emergency department out-of-pocket expenditures by insurance, 1999 to 2016. Ann Emerg Med. 2019;74(3):317-324. - PubMed
-
- Scott JW, Raykar NP, Rose JA, et al. Cured into destitution: catastrophic health expenditure risk among uninsured trauma patients in the United States. Ann Surg. 2018;267(6):1093-1099. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources